NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings

8-K - Aditxt, Inc. - 1.01 / 2.03 / 9.01

Filed: 2026-04-14 AccNo: 0001213900-26-043227 Size: 416 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits
发布时间04/14 12:00 UTC
首次发现04/14 12:04 UTC
热度106.6
重要度78
情绪-0.04

站内整理正文

优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 895 字符

Form 8-K - Current report: SEC Accession No. 0001213900-26-043227

Filing Date: 2026-04-14

Accepted: 2026-04-14 08:00:13

Documents: 12

Period of Report: 2026-04-10

Items: Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

Aditxt, Inc. (Filer) CIK : 0001726711 (see all company filings) EIN. : 823204328 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 26859191 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | CURRENT REPORT | ea0286168-8k_aditxt.htm iXBRL | 8-K

2 | FORM OF NOTE (APRIL 2026) | ea028616801ex10-1.htm | EX-10.1

3 | XBRL SCHEMA FILE | adtx-20260410.xsd | EX-101.SCH

4 | XBRL LABEL FILE | adtx-20260410_lab.xml | EX-101.LAB